semaglutide and covid Breaking news: Wegovy lowered Covid-19 mortality in landmark trial Wegovy reduced deaths from Covid-19?
Description
Learn why it might happen, what it means, and how to manage this common side effect
GLP -1
Peripheral neuropathy affects millions of diabetic patients, and emerging data suggests a complex relationship with GLP-1 therapy
On Friday, June 13, a federal judge officially sided with the FDA and Novo Nordisk in the lawsuit brought by the Outsourcing Facilities Association over compounded semaglutide.
Long-term trials, cost-effectiveness studies, and comparative analyses are needed to solidify its role in clinical practice, particularly across diverse HFpEF subgroups.
